Scientists and journalists don't always see the world the same way. A "first" often makes news. But in science, the "second" -that is the confirmation -may actually be more important. Journalists are like toddlers, though, when it comes to seconds. They often need coaxing. Consider two recent cases.
First, Neanderthal DNA. Back in 1997, reporters made a bit of a fuss when scientists announced that they had extracted DNA from Neanderthal remains for the first time. In late March, Nature published a second such find. A News and Views comment accompanying the story made a strong argument that the second find was scientifically more interesting than the first. It not only provided much welcomed corroboration, given how prone to error the technology is, but the discovery opened up the prospect of a whole new discipline -Neanderthal genetics -assuming, of course, that more genetic material would be forthcoming.
Cerebral science writers mused over this story, but had to find a better angle than the actual scientific value -that is, the confirmation that the first find was genuine. That simply wasn't grabby. Instead, reporters settled on a sub-plot: the new find suggests that humans and Neanderthals did not interbreed, as some researchers had argued of late.
That was a reasonable tidbit to report -and for editors to bury, with headlines such as "Study Challenges Neanderthal Link" (USA Today, page 7), or "Neanderthals Ruled Out" (Daily Telegraph, page 5). Well, not all news, and especially science news, can fit on page 1.
In the second example, readers around the globe woke up the morning of March 15 to page 1 news about something that wasn't a first. It wasn't even a second or a third. The fourth mammal to be cloned still managed to grab attention, thanks to a carefully orchestrated media release, cute and cuddly pictures (a sure draw for TV), endearing names and abundant claims of good health and good fortune.
"Five little piggies are going into the record books as the first of their species to be cloned," the New York Daily News reported, "bringing ever closer the possibility of animalto-human transplantation." Officials from PPL Therapeutics, the company that produced the pigs at its research center in Virginia, were downright exuberant about the prospects in news interviews. "An end to the chronic organ shortage is now in sight," Ron James, managing director of the company told the Irish Times, among others.
"The fourth mammal to be cloned still managed to grab attention" PPL Therapeutics announced their achievement by press release, ten days after the five piglets were born. Sticklers for peer review may have grumbled a bit, but stockholders didn't -the value of a share in the company jumped 19 percent in a day.
On ABC's World News Tonight, PPL Therapeutics Vice President David Ayares boasted, "we're going to be able to revolutionize the transplant field, and in the near term, be able to solve the worldwide organ shortage crisis." As US News and World Report proclaimed: "Not since E.B. White's pig Wilbur, has a lowly swine been so celebrated." Even the pigs' names were cute -Dotcom was so-named because "Any association with dotcoms right now seems to have a very positive influence on a company's valuation," Ron James, told The Guardian (and anyone else who cared to ask).
Not everyone was swept away, though. The New York Times, which had gone hog wild over Dolly the lamb, was much more circumspect about the pigs, placing a dry story on page 21, epitomized by lines like: "Dr. David Ayares…said yesterday that he hoped the announcement would attract investors." London's Daily Mail backed into the news with this headline: "Are the scientists risking a new BSE?" and claiming that the "announcement triggered a storm of controversy", although it looked more like a localized squall directly over the newspaper in question.
To be sure, as the week progressed, journalists started to wonder more loudly whether cloning a pig really burst the dam that has been holding back xenotransplantation. "Most overblown and misleading is the PPL claim that with its success at cloning pigs, 'all the known technical hurdles to cross-species transplants have been overcome' ," The Los Angeles Times declared in an editorial. "Actually, scientists are far from mastering the very complex procedures that will be necessary to prevent human immune systems from rejecting organs from pigs or any other species," it continued.
The Washington Post, which had splashed the story across page 1 initially, came back five days later with a more studious story headlined, "In Organ Quest, Cloning Pigs May Be the Easy Part." This time, readers were treated to a walk through the world of H transferase and α 1-3 galactose, as they discovered that pig organs for transplants aren't likely to rumble off the assembly line like so many Virginia hams, at least not anytime soon. 
